Cover Image
市場調查報告書

大腸癌:全球臨床實驗檢討

Colon Cancer Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 146301
出版日期 內容資訊 英文 603 Pages
訂單完成後即時交付
價格
Back to Top
大腸癌:全球臨床實驗檢討 Colon Cancer Global Clinical Trials Review, H1, 2017
出版日期: 2017年06月30日 內容資訊: 英文 603 Pages
簡介

本報告提供全球主要地區的大腸癌症治療藥臨床實驗數和受驗人數,各階段趨勢,再加上主要企業和機關,臨床實驗簡介等。

簡介

  • 大腸癌
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區前五名國家的臨床實驗數量
    • 歐洲前五名國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量 大腸癌

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

參與大腸癌臨床實驗的主要企業

有潛力的藥劑

最新臨床實驗新聞 大腸癌

臨床實驗簡介

  • 主要企業臨床實驗概要
    • F. Hoffmann-La Roche Ltd.
    • Sanofi
    • Pfizer Inc.
    • Novartis AG
    • Amgen Inc.
    • GlaxoSmithKline plc
    • Immunomedics, Inc.
    • Eli Lilly and Company
    • AstraZeneca PLC
  • 代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Memorial Sloan Kettering Cancer Center
    • The University of Texas M. D. Anderson Cancer Center
    • Stanford University
    • Barbara Ann Karmanos Cancer Institute
    • Mayo Clinic
    • Ohio State University Comprehensive Cancer Center
    • 昭和大學橫濱市北部醫院
    • Alberta Health Services
    • 大阪消化道癌化療研究會

5個代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4320CTIDB

GlobalData's clinical trial report, "Colon Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Colon Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Colon Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Five Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Colon Cancer to Oncology Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Colon Cancer to Oncology Clinical Trials 20
  • Clinical Trials by Phase in E7 Countries 21
  • Clinical Trials in E7 Countries by Trial Status 22
  • Clinical Trials by Phase 24
  • In Progress Trials by Phase 25
  • Clinical Trials by Trial Status 26
  • Clinical Trials by End Point Status 28
  • Subjects Recruited Over a Period of Time 29
  • Clinical Trials by Sponsor Type 30
  • Prominent Sponsors 31
  • Top Companies Participating in Colon Cancer Therapeutics Clinical Trials 33
  • Prominent Drugs 35
  • Latest Clinical Trials News on Colon Cancer 36
  • Jun 28, 2017: Mateon Therapeutics Announces New Interim Preclinical Data on CA4P in Combination with Checkpoint Inhibitors 36
  • Jun 27, 2017: MabVax Therapeutics Commences Patient Dosing in MVT-1075 Radioimmunotherapy Phase 1 Clinical Trial for the Treatment of Pancreatic, Colon and Lung Cancers 36
  • Jun 22, 2017: Recce constructs automated manufacturing facility to support clinical trials 36
  • Jun 12, 2017: New cancer drug makes commonly prescribed chemo drug more effective when given together 37
  • Jun 07, 2017: Spring Bank Provides Update on its Next-Generation STING Platform and Announces Publication of an Abstract at ASCO Related to its Lead STING Agonist Candidate, SB 11285 37
  • Jun 06, 2017: DEP irinotecan outperforms irinotecan in multiple cancer models 38
  • May 10, 2017: Loxo Oncology Announces Enrollment of First Patient in Phase 1 Clinical Trial for Highly Selective RET Inhibitor, LOXO-292 39
  • Apr 07, 2017: Allegheny Health Network Clinical Trial Examines Kinase Inhibitor Regorafenib as Maintenance Therapy for Colon Cancer 39
  • Clinical Trial Profile Snapshots 40

Appendix 601

  • Abbreviations 601
  • Definitions 601
  • Research Methodology 602
  • Secondary Research 602
  • About GlobalData 603
  • Contact Us 603
  • Disclaimer 603
  • Source 603

List of Tables

List of Tables

  • Colon Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 8
  • Colon Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Colon Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Colon Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Colon Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Colon Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
  • Colon Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
  • Proportion of Colon Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 16
  • Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Proportion of Colon Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 20
  • Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
  • Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
  • Colon Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 24
  • Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 25
  • Colon Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 27
  • Colon Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 28
  • Colon Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 29
  • Colon Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 30
  • Colon Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 32
  • Colon Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 34
  • Colon Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 35

List of Figures

List of Figures

  • Colon Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
  • Colon Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Colon Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
  • Colon Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Colon Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Colon Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
  • Colon Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
  • Proportion of Colon Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 16
  • Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Colon Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 20
  • Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
  • Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
  • Colon Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 24
  • Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 25
  • Colon Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26
  • Colon Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 28
  • Colon Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 29
  • Colon Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 30
  • Colon Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 31
  • Colon Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 33
  • Colon Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 35
  • GlobalData Methodology 602
Back to Top